Showing results (551-560 of 659) with videos related to

Sort By:
Pageof 66
The Lancet. Microbe|May 11, 2022
Uncovering the novel Enterobacter cloacae complex species responsible for septic shock deaths in newborns: a cohort studyDelphine Girlich, Souad Ouzani, Cécile Emeraud, et al.
The Lancet. Microbe|May 11, 2022
Seroprevalence of chikungunya virus infection in India, 2017: a cross-sectional population-based serosurveyMuthusamy Santhosh Kumar, Pattabi Kamaraj, Siraj Ahmed Khan, et al.
The Lancet. Microbe|May 11, 2022
Estimation of the correlates of protection of the rVSVΔG-ZEBOV-GP Zaire ebolavirus vaccine: a post-hoc analysis of data from phase 2/3 clinical trialsRebecca F Grais, Stephen B Kennedy, Barbara E Mahon, et al.
The Lancet. Microbe|May 11, 2022
Whole-genome sequencing of Mycobacterium tuberculosis directly from clinical samples for high-resolution genomic epidemiology and drug resistance surveillance: an observational studyGalo A Goig, Irving Cancino-Muñoz, Manuela Torres-Puente, et al.
The Lancet. Microbe|May 26, 2022
Evaluation of viral load in patients with Ebola virus disease in Liberia: a retrospective observational studyM Jeremiah Matson, Emily Ricotta, Friederike Feldmann, et al.
The Lancet. Microbe|May 11, 2022
Dynamics of mcr-1 prevalence and mcr-1-positive Escherichia coli after the cessation of colistin use as a feed additive for animals in China: a prospective cross-sectional and whole genome sequencing-based molecular epidemiological studyCong Shen, Lan-Lan Zhong, Yongqiang Yang, et al.
The Lancet. Microbe|July 26, 2021
Correction to Lancet Microbe 2020; published online July 6. https://doi.org/10.1016/S2666-5247(21)00146-4
The Lancet. Microbe|April 22, 2023
Tracking antimalarial drug resistance using mosquito blood meals: a cross-sectional studyHanna Y Ehrlich, A Fabrice Somé, Thomas Bazié, et al.
The Lancet. Microbe|April 1, 2023
Bedaquiline and clofazimine resistance in Mycobacterium tuberculosis: an in-vitro and in-silico data analysisLindsay Sonnenkalb, Joshua James Carter, Andrea Spitaleri, et al.
The Lancet. Microbe|March 15, 2022
Safety and immunogenicity of a synthetic multiantigen modified vaccinia virus Ankara-based COVID-19 vaccine (COH04S1): an open-label and randomised, phase 1 trialFlavia Chiuppesi, John A Zaia, Paul H Frankel, et al.
Pageof 66